Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Deen

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Radiation Research|December 1, 1978
The concept of drug dose for in vitro studies with chemotherapeutic agentsK T Wheeler, V A Levin, D F Deen
European Journal of Cancer & Clinical Oncology|October 1, 1983
The relative resistance of non-cycling cells in 9L multicellular spheroids to spirohydantoin mustardY Sano, T Hoshino, R Bjerkvig, et al.
Science (New York, N.Y.)|November 20, 1992
Polyamine depletion and drug-induced chromosomal damage: new resultsP J Tofilon, D F Deen, L J Marton
International Journal of Radiation Oncology, Biology, Physics|September 1, 1979
Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9L brain tumor cells of ratsD F Deen, M E Williams, K T Wheeler
Cell and Tissue Kinetics|May 1, 1989
Cell proliferation and polyamine metabolism in 9L cells treated with (2R,5R)-6-heptyne-2,5-diamine or alpha-difluoromethylornithineK M Milam, D F Deen, L J Marton
Cancer Chemotherapy and Pharmacology|January 1, 1987
Response to BCNU of spheroids grown from mixtures of drug-sensitive and drug-resistant cellsP J Tofilon, C M Arundel, D F Deen
Cancer Research|October 15, 1987
Changes in the glutathione content of rat 9L cells induced by treatment with the ornithine decarboxylase inhibitor alpha-difluoromethylornithineK J Hunter, D F Deen, L J Marton
European Journal of Cancer & Clinical Oncology|August 1, 1985
The effect of treatment with single and split doses of spirohydantoin mustard on the growth delay of 9L rat brain tumor multicellular spheroidsR F Jostes, M E Williams, D F Deen
Cancer Treatment Reports|May 1, 1983
Paradoxical behavior of 6-mercaptopurine as a cytotoxic agent: decreasing cell kill with increasing drug doseS Matsumura, T Hoshino, M Weizsaecker, et al.
Cancer Research|February 1, 1984
Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosoureaY Sano, T Hoshino, M Barker, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Radiation Research|December 1, 1978
The concept of drug dose for in vitro studies with chemotherapeutic agentsK T Wheeler, V A Levin, D F Deen
European Journal of Cancer & Clinical Oncology|October 1, 1983
The relative resistance of non-cycling cells in 9L multicellular spheroids to spirohydantoin mustardY Sano, T Hoshino, R Bjerkvig, et al.
Science (New York, N.Y.)|November 20, 1992
Polyamine depletion and drug-induced chromosomal damage: new resultsP J Tofilon, D F Deen, L J Marton
International Journal of Radiation Oncology, Biology, Physics|September 1, 1979
Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9L brain tumor cells of ratsD F Deen, M E Williams, K T Wheeler
Cell and Tissue Kinetics|May 1, 1989
Cell proliferation and polyamine metabolism in 9L cells treated with (2R,5R)-6-heptyne-2,5-diamine or alpha-difluoromethylornithineK M Milam, D F Deen, L J Marton
Cancer Chemotherapy and Pharmacology|January 1, 1987
Response to BCNU of spheroids grown from mixtures of drug-sensitive and drug-resistant cellsP J Tofilon, C M Arundel, D F Deen
Cancer Research|October 15, 1987
Changes in the glutathione content of rat 9L cells induced by treatment with the ornithine decarboxylase inhibitor alpha-difluoromethylornithineK J Hunter, D F Deen, L J Marton
European Journal of Cancer & Clinical Oncology|August 1, 1985
The effect of treatment with single and split doses of spirohydantoin mustard on the growth delay of 9L rat brain tumor multicellular spheroidsR F Jostes, M E Williams, D F Deen
Cancer Treatment Reports|May 1, 1983
Paradoxical behavior of 6-mercaptopurine as a cytotoxic agent: decreasing cell kill with increasing drug doseS Matsumura, T Hoshino, M Weizsaecker, et al.
Cancer Research|February 1, 1984
Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosoureaY Sano, T Hoshino, M Barker, et al.
Pageof 13